Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
Hung-Yang Kuo & Robert S. Kerbel et al.
· 2024
Links
DOI
Journal
Unknown Journal
Authors
Hung-Yang Kuo
,
Kabir A. Khan
,
Robert S. Kerbel